851 results on '"Kanis, J."'
Search Results
2. Comparing Prevalence of Sarcopenia Using Twelve Sarcopenia Definitions in a Large Multinational European Population of Community-Dwelling Older Adults
3. Effects of Vitamin D, Omega-3 Fatty Acids and a Home Exercise Program on Prevention of Pre-Frailty in Older Adults: The DO-HEALTH Randomized Clinical Trial
4. A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
5. Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
6. Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
7. Prevalence of Physical Frailty: Results from the DO-HEALTH Study
8. FRAX-based intervention thresholds for Pakistan
9. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines: A report for the National Osteoporosis Guideline Group (NOGG)
10. Impact of population-based or targeted BMD interventions on fracture incidence
11. The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture
12. Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study
13. A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis
14. Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women
15. The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
16. Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
17. A surrogate FRAX model for Pakistan
18. A country-specific FRAX model for Botswana
19. Epidemiology of hip fracture in Botswana
20. Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study
21. Increased risk for hip fracture after death of a spouse—further support for bereavement frailty?
22. Harmonization of commercial assays for PINP; the way forward
23. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
24. Influence of fall environment and fall direction on risk of injury among pre-frail and frail adults
25. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis.
26. Extensive undertreatment of osteoporosis in older Swedish women
27. A surrogate FRAX model for the Kyrgyz Republic
28. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women
29. Characteristics of recurrent fractures
30. Review of the guideline of the American College of Physicians on the treatment of osteoporosis
31. Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS)
32. Bone health assessment in older people with or without muscle health impairment
33. FRAX-based intervention and assessment thresholds in seven Latin American countries
34. Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
35. A health economic simulation model for the clinical management of osteoporosis
36. Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry
37. Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers
38. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry
39. UK clinical guideline for the prevention and treatment of osteoporosis
40. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement
41. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
42. Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464)
43. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry
44. FRAX- vs. T-score-based intervention thresholds for osteoporosis
45. Imminent risk of fracture after fracture
46. International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
47. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK—an analysis of anonymous website activity
48. Increased risk of hip fracture among spouses—evidence of a homogamy effect
49. Schlaf, Kindlein, schlaf?: Eine Inhaltsanalyse von Elternratgebern zu Schlafproblemen bei Babys
50. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.